Skip to content

Clinical trials

Medulloblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Country / region: Canada Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20052
20072
20081
20103
20111
20133
20142
20152
20161
20172
20183
20193
20211
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting11
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group13
National Cancer Institute (NCI)12
Novartis Pharmaceuticals2
British Columbia Cancer Agency1
C17 Council1
Cellectar Biosciences, Inc.1
Children's Hospital Los Angeles1
Dana-Farber Cancer Institute1
Donald Mabbott1
Giselle Sholler1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma42
Central Nervous System Neoplasms19
Astrocytoma15
Neuroblastoma14
Oligodendroglioma11
Optic Nerve Glioma11
Rhabdoid Tumor11
Sarcoma11
Brain Neoplasms9
Ependymoma9

Trials

Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.